General Information of Drug (ID: DMQ7KR1)

Drug Name
Bis(2,3-dibromo-4,5-dihydroxyphenyl)ether Drug Info
Synonyms CHEMBL1269935; Bis(2,3-dibromo-4,5-dihydroxyphenyl)ether; SCHEMBL15511613; BDBM50329693
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
52944683
TTD Drug ID
DMQ7KR1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrohalisulfate 1 DM0HQF6 Discovery agent N.A. Investigative [2]
Halisulfate 1 DMJB87Q Discovery agent N.A. Investigative [2]
2,2',3-Tribromo-4,4',5,5'-tetrahydroxybibenzyl DMG7EPF Discovery agent N.A. Investigative [1]
3-bromopyruvate DMYL3ST Discovery agent N.A. Investigative [3]
Bis(3-bromo-4,5-dihydroxyphenyl)methanone DMUN50H Discovery agent N.A. Investigative [1]
5,5'-methylenebis(3,4-dibromobenzene-1,2-diol) DMZ693W Discovery agent N.A. Investigative [1]
Glyoxalate, Glyoxylate DMQUP7O Discovery agent N.A. Investigative [4]
3-nitropropionate DMH798G Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mycobacterium Isocitrate lyase (MycB icl) TT58ZYW ACEA_MYCTU Inhibitor [1]

References

1 Bromophenols as Candida albicans isocitrate lyase inhibitors. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6644-8.
2 Sesterterpene sulfates as isocitrate lyase inhibitors from tropical sponge Hippospongia sp. Bioorg Med Chem Lett. 2007 May 1;17(9):2483-6.
3 Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol. 2000 Aug;7(8):663-8.
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.